Published Date: March 2025
In vitro fertilization (IVF) service provides medical treatments and services related to IVF, in which an egg and sperm are combined outside the body to achieve pregnancy. IVF can be used in various fertility issues, such as fallopian tubes, low sperm count, ovulation disorder, endometriosis and genetic concerns. The increasing awareness about fertility issues and treatments, more individuals are encourage to seek treatment, resulting to drive IVF services market growth.
In Vitro Fertilization (IVF) Service Market Segmentation Analysis:
By Type |
Fresh IVF Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle |
By End-User |
Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes |
In Vitro Fertilization (IVF) Service Market Report Highlights:
- Valuation of the in vitro fertilization (IVF) service market was worth at USD 1019.3 Million in 2024.
- In vitro fertilization (IVF) service market size is predictable to reach at 4838.7 Million by 2034 and grow at a CAGR of 18.7%.
- Based on type, fresh IVF cycles segment holds the largest in vitro fertilization (IVF) service market share
- By end-user, the in vitro fertilization (IVF) service market is being dominated by the fertility clinics segment
- North America holds the largest market share.
- Asia Pacific is predicted to be highest growing region in in vitro fertilization (IVF) service market.
In Vitro Fertilization (IVF) Service Market Dynamics:
Growing Factor |
Challenge Factor |
Market Trend |
Rising Collaboration with Hospitals and Fertility Networks |
Complexity of Procedures |
Advancement in Male Infertility Treatment |
In Vitro Fertilization (IVF) Service Market Key Highlights
- In September 2024, MGM Healthcare launched their In-Vitro Fertilization (IVF) services, known as Varam IVF Center. Varam IVF’s services, include ovarian stimulation, intrauterine insemination (IUI), in vitro fertilization (IVF), and intracytoplasmic sperm injection. This center aimed to provide advanced fertility treatments and personalized care, together to provide ancillary services and state-of-the-art technology.
In Vitro Fertilization (IVF) Service Market Report Analysis:
Taking Medication During In Vitro Fertilization:
Medication help stimulate the ovaries and control the timing of ovulation for optimal egg retrieval, during in vitro fertilization procedure.
·Gonadotrophins (FSH and LH):
- These medication are designed to stimulate the ovaries to produce multiple follicles, each containing an egg, to increase the chances of successful fertilization.
·Human Chorionic Gonadotrophin (hCG):
- hCG is used to trigger the final maturation of eggs after the ovaries have been stimulated with FSH (Follicle Stimulating Hormone). It mimics the natural LH (Luteinizing Hormone), which signals ovulation, and helps to egg release.
·Luteinising Hormone (LH):
- LH is used in patients with low levels of the hormone, which may affect ovulation. It helps stimulate the development of follicles in combination with FSH.
·Gonadotrophin-Releasing Hormone (GnRH) Agonists:
- GnRH agonists help control the body’s natural hormone levels during fertility treatments. They initially stimulate the pituitary gland to release more FSH and LH, but then suppress their production, effectively by limiting the natural menstrual cycle.
Browse ∼60 market data tables and ∼35 figures through ∼140 slides and in-depth TOC on “In Vitro Fertilization (IVF) Service Market, Size, Share, By Type (Fresh IVF Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle), End-User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), and Region - Trends, Analysis, and Forecast till 2034”
For more insights into the In Vitro Fertilization (IVF) Service Market and its future trends, visit the link: https://www.prophecymarketinsights.com/market_insight/in-vitro-fertilization-ivf-service-market-5566
Competitive Landscape of In Vitro Fertilization (IVF) Service Market:
The key players operating in the in vitro fertilization (IVF) service market are Columbia University Fertility Center, Boston IVF, LLC., Shady Grove Fertility Center, Fertility Centers of Illinois, Cleveland Clinic Fertility Center, Reproductive Medicine Associates, Houston Fertility Institute, Mayo Clinic Fertility Center, Pacific Fertility Center, and Colorado Center for Reproductive Medicine.
Company Name |
Boston IVF, LLC. |
Headquarter |
Massachusetts, U.S. |
CEO |
David Stern |
Employee Count (2024) |
332 Employees |
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Custmoized Your ReportWe help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request for Discount



Quick contact
